By |

Guy Levy-Yurista is an accomplished executive with deep multidisciplinary experience across science, technology and business.

He specializes in commercializing advanced technologies in fast-changing market environments and has previously served as the Chief Strategy Officer for Sisense, a hyper-growth big data company.

Guy holds a PhD in Physics, an MBA from the Wharton Business School, and is a graduate of the Talpiot program.

He lives in Washington DC with his wife, three daughters, and his guitar – which he never seems to get enough practice with.

Guy joins Louisa “Wizzi” Magnussen to discuss The Business of Science Innovation…

By |

Sarah Asquith-Vallance is an award winning neuroscientist, money & success mentor and coach. 

She is the creator of The Empowered Mind: A Money & Success Mindset and Brain Training brand that supports entrepreneurs to grow their business with mindset led, brain science backed solutions so that they can achieve consistent financial and time freedom.

This is the Business of Neuroscience, Money & Success…

By |

Peter Birch is a Company Director at MetaOptima, creating intelligent technology to help doctors detect and treat skin cancer, and Company Director of the Medical Software Industry Association (MSIA), representing the software vendors of the healthcare industry in Australia.

Based in Sydney, Australia, in 2021 Pete left his full time role as a senior executive to run his business full time.

He’s also the creator and host of Talking HealthTech; a podcast and membership community for people passionate about connecting and learning about the effective use of technology in healthcare.

Peter joins Louisa “Wizzi” Magnussen discuss the Business of Health Technology…

By |

At the time of recording, Dr Michael Magnussen was a final year PhD student at the UCL Great Ormond Street Institute for Child Health. 

Michael’s focus over his studies has been to develop human tissue engineered models for heart development. The purpose of which is to overcome discrepancies between leading animal models such as mice and fish in favour of human models of tissue development. And to enhance global adoption of the three Rs; 

  • Reduction; of the number of animals used in research
  • Refinement; focusing on enhanced human focused modeling for the purpose of more accurate study of the human heart.
  • Replacement; to develop methods which avoid or replace the use of animals. 

Since recording he has embarked on a post doc position at DanStem based at the University of Copenhagen where Michael is continuing his research in the field of stem cell biology. He is here with Louisa “Wizzi” Magnussen today to discuss The Business of Bioengineering…